These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 22635106

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells.
    Chen L, Chen D, Gong M, Na M, Li L, Wu H, Jiang L, Qian Y, Fang G, Xue X.
    Cancer Lett; 2009 Nov 01; 284(2):141-8. PubMed ID: 19447545
    [Abstract] [Full Text] [Related]

  • 23. [Security of dual cancer-specific targeting vector and its cytotoxic effect when harbored].
    Wang J, Gu JF, Yang SY, Xiao T, Qi R, Sun LY, Liu XY.
    Ai Zheng; 2006 Apr 01; 25(4):385-92. PubMed ID: 16613667
    [Abstract] [Full Text] [Related]

  • 24. Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer.
    Zhao L, Gu J, Dong A, Zhang Y, Zhong L, He L, Wang Y, Zhang J, Zhang Z, Huiwang J, Qian Q, Qian C, Liu X.
    Hum Gene Ther; 2005 Jul 01; 16(7):845-58. PubMed ID: 16000066
    [Abstract] [Full Text] [Related]

  • 25. Combination of vorinostat and adenovirus-TRAIL exhibits a synergistic antitumor effect by increasing transduction and transcription of TRAIL in lung cancer cells.
    Kim DR, Park MY, Lee CS, Shim SH, Yoon HI, Lee JH, Sung MW, Kim YS, Lee CT.
    Cancer Gene Ther; 2011 Jul 01; 18(7):467-77. PubMed ID: 21455254
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Tumor suppressor XIAP-Associated factor 1 (XAF1) cooperates with tumor necrosis factor-related apoptosis-inducing ligand to suppress colon cancer growth and trigger tumor regression.
    Tu SP, Sun YW, Cui JT, Zou B, Lin MC, Gu Q, Jiang SH, Kung HF, Korneluk RG, Wong BC.
    Cancer; 2010 Mar 01; 116(5):1252-63. PubMed ID: 20082449
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Itashiki Y, Harada K, Ferdous T, Yoshida H.
    Anticancer Res; 2007 Mar 01; 27(4B):2365-75. PubMed ID: 17695527
    [Abstract] [Full Text] [Related]

  • 30. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.
    Singh TR, Shankar S, Chen X, Asim M, Srivastava RK.
    Cancer Res; 2003 Sep 01; 63(17):5390-400. PubMed ID: 14500373
    [Abstract] [Full Text] [Related]

  • 31. Synergistic Anti-tumour Effects of Quercetin and Oncolytic Adenovirus expressing TRAIL in Human Hepatocellular Carcinoma.
    Zou H, Zheng YF, Ge W, Wang SB, Mou XZ.
    Sci Rep; 2018 Feb 01; 8(1):2182. PubMed ID: 29391509
    [Abstract] [Full Text] [Related]

  • 32. Synergistic combination of histone deacetylase inhibitor suberoylanilide hydroxamic acid and oncolytic adenovirus ZD55-TRAIL as a therapy against cervical cancer.
    Han X, Wang S, Zhou W, Li Y, Lei W, Lv W.
    Mol Med Rep; 2015 Jul 01; 12(1):435-41. PubMed ID: 25684632
    [Abstract] [Full Text] [Related]

  • 33. Enhanced anti-tumor activity by the combination of a conditionally replicating adenovirus mediated interleukin-24 and dacarbazine against melanoma cells via induction of apoptosis.
    Jiang G, Liu YQ, Wei ZP, Pei DS, Mao LJ, Zheng JN.
    Cancer Lett; 2010 Aug 28; 294(2):220-8. PubMed ID: 20189296
    [Abstract] [Full Text] [Related]

  • 34. Enhanced antitumor effect of combining interferon beta with TRAIL mediated by tumor-targeting adeno-associated virus vector on A549 lung cancer xenograft.
    Wang Y, He L, He G, Kong Y, Liu X, Cai H, Liu X, Tan W.
    Sheng Wu Gong Cheng Xue Bao; 2010 Jun 28; 26(6):780-8. PubMed ID: 20815258
    [Abstract] [Full Text] [Related]

  • 35. Antitumor activity of a novel recombinant mutant human tumor necrosis factor-related apoptosis-inducing ligand.
    Fang F, Wang AP, Yang SF.
    Acta Pharmacol Sin; 2005 Nov 28; 26(11):1373-81. PubMed ID: 16225761
    [Abstract] [Full Text] [Related]

  • 36. A novel combination of TRAIL and doxorubicin enhances antitumor effect based on passive tumor-targeting of liposomes.
    Guo L, Fan L, Ren J, Pang Z, Ren Y, Li J, Wen Z, Jiang X.
    Nanotechnology; 2011 Jul 01; 22(26):265105. PubMed ID: 21586819
    [Abstract] [Full Text] [Related]

  • 37. Luteolin enhances TNF-related apoptosis-inducing ligand's anticancer activity in a lung cancer xenograft mouse model.
    Yan J, Wang Q, Zheng X, Sun H, Zhou Y, Li D, Lin Y, Wang X.
    Biochem Biophys Res Commun; 2012 Jan 13; 417(2):842-6. PubMed ID: 22206675
    [Abstract] [Full Text] [Related]

  • 38. Combination of Targeting Gene-ViroTherapy with 5-FU enhances antitumor efficacy in malignant colorectal carcinoma.
    Qiu S, Ruan H, Pei Z, Hu B, Lan P, Wang J, Zhang Z, Gu J, Sun L, Qian C, Liu X, Qi Y.
    J Interferon Cytokine Res; 2004 Apr 13; 24(4):219-30. PubMed ID: 15144568
    [Abstract] [Full Text] [Related]

  • 39. Ad-KDRscFv:sTRAIL displays a synergistic antitumor effect without obvious cytotoxicity to normal tissues.
    Yang L, Guo J, Wang J, Wan S, Yang S, Wang R, Chen W, Peng G, Fang D.
    Int Immunopharmacol; 2012 May 13; 13(1):37-45. PubMed ID: 22406047
    [Abstract] [Full Text] [Related]

  • 40. Radiation-inducible human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene therapy: a novel treatment for radioresistant uveal melanoma.
    Zhou Y, Song X, Jia R, Wang H, Dai L, Xu X, Gu P, Ge S, Fan X.
    Pigment Cell Melanoma Res; 2010 Oct 13; 23(5):661-74. PubMed ID: 20546535
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.